Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 99

1.

Understanding the dose-response relationship of allopurinol: predicting the optimal dosage.

Graham GG, Kannangara DR, Stocker SL, Portek I, Pile KD, Indraratna PL, Datta I, Williams KM, Day RO.

Br J Clin Pharmacol. 2013 Dec;76(6):932-8. doi: 10.1111/bcp.12126.

PMID:
23590252
[PubMed - in process]
2.

The optimal use of allopurinol: an audit of allopurinol use in South Auckland.

Stamp L, Gow P, Sharples K, Raill B.

Aust N Z J Med. 2000 Oct;30(5):567-72.

PMID:
11108066
[PubMed - indexed for MEDLINE]
3.

Relationship between serum urate and plasma oxypurinol in the management of gout: determination of minimum plasma oxypurinol concentration to achieve a target serum urate level.

Stamp LK, Barclay ML, O'Donnell JL, Zhang M, Drake J, Frampton C, Chapman PT.

Clin Pharmacol Ther. 2011 Sep;90(3):392-8. doi: 10.1038/clpt.2011.113. Epub 2011 Jul 27.

PMID:
21796116
[PubMed - indexed for MEDLINE]
4.

Allopurinol dosage selection: relationships between dose and plasma oxipurinol and urate concentrations and urinary urate excretion.

Day RO, Miners JO, Birkett DJ, Whitehead A, Naidoo D, Hayes J, Savdie E.

Br J Clin Pharmacol. 1988 Oct;26(4):423-8.

PMID:
3190992
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Higher therapeutic plasma oxypurinol concentrations might be required for gouty patients with chronic kidney disease.

Panomvana D, Sripradit S, Angthararak S.

J Clin Rheumatol. 2008 Feb;14(1):6-11. doi: 10.1097/RHU.0b013e318164dceb.

PMID:
18431090
[PubMed - indexed for MEDLINE]
6.

Efficacy of allopurinol and benzbromarone for the control of hyperuricaemia. A pathogenic approach to the treatment of primary chronic gout.

Perez-Ruiz F, Alonso-Ruiz A, Calabozo M, Herrero-Beites A, GarcĂ­a-Erauskin G, Ruiz-Lucea E.

Ann Rheum Dis. 1998 Sep;57(9):545-9.

PMID:
9849314
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

Myeloperoxidase and oxidation of uric acid in gout: implications for the clinical consequences of hyperuricaemia.

Stamp LK, Turner R, Khalilova IS, Zhang M, Drake J, Forbes LV, Kettle AJ.

Rheumatology (Oxford). 2014 Jun 4. pii: keu218. [Epub ahead of print]

PMID:
24899662
[PubMed - as supplied by publisher]
8.

An audit of a therapeutic drug monitoring service for allopurinol therapy.

Kannangara DR, Ramasamy SN, Ray JE, Jones G, Graham GG, Williams KM, Day RO.

Ther Drug Monit. 2013 Dec;35(6):863-6. doi: 10.1097/FTD.0b013e318299920a.

PMID:
24263644
[PubMed - in process]
9.

Pharmacokinetic and pharmacodynamic interaction between allopurinol and probenecid in healthy subjects.

Stocker SL, Williams KM, McLachlan AJ, Graham GG, Day RO.

Clin Pharmacokinet. 2008;47(2):111-8.

PMID:
18193917
[PubMed - indexed for MEDLINE]
10.

Fenofibrate enhances urate reduction in men treated with allopurinol for hyperuricaemia and gout.

Feher MD, Hepburn AL, Hogarth MB, Ball SG, Kaye SA.

Rheumatology (Oxford). 2003 Feb;42(2):321-5.

PMID:
12595630
[PubMed - indexed for MEDLINE]
Free Article
11.

[Usefulness of combination treatment using allopurinol and benzbromarone for gout and hyperuricemia accompanying renal dysfunction: kinetic analysis of oxypurinol].

Ohno I, Okabe H, Yamaguchi Y, Saikawa H, Uetake D, Hikita M, Gomi H, Ichida K, Hosoya T.

Nihon Jinzo Gakkai Shi. 2008;50(4):506-12. Japanese.

PMID:
18546882
[PubMed - indexed for MEDLINE]
12.

Optimizing therapy with allopurinol: factors limiting hypouricemic efficacy.

Chung Y, Stocker SL, Graham GG, Day RO.

Am J Med Sci. 2008 Mar;335(3):219-26. doi: 10.1097/MAJ.0b013e31815acb10. Review.

PMID:
18344696
[PubMed - indexed for MEDLINE]
13.

Prescription and dosing of urate-lowering therapy, rather than patient behaviours, are the key modifiable factors associated with targeting serum urate in gout.

Dalbeth N, House ME, Horne A, Petrie KJ, McQueen FM, Taylor WJ.

BMC Musculoskelet Disord. 2012 Sep 16;13:174. doi: 10.1186/1471-2474-13-174.

PMID:
22978848
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

Effect of allopurinol versus urate oxidase on methotrexate pharmacokinetics in children with newly diagnosed acute lymphoblastic leukemia.

Crews KR, Zhou Y, Pauley JL, Howard SC, Jeha S, Relling MV, Pui CH.

Cancer. 2010 Jan 1;116(1):227-32. doi: 10.1002/cncr.24681.

PMID:
19834958
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

Clinical pharmacokinetics and pharmacodynamics of allopurinol and oxypurinol.

Day RO, Graham GG, Hicks M, McLachlan AJ, Stocker SL, Williams KM.

Clin Pharmacokinet. 2007;46(8):623-44. Review.

PMID:
17655371
[PubMed - indexed for MEDLINE]
16.

Effects of febuxostat versus allopurinol and placebo in reducing serum urate in subjects with hyperuricemia and gout: a 28-week, phase III, randomized, double-blind, parallel-group trial.

Schumacher HR Jr, Becker MA, Wortmann RL, Macdonald PA, Hunt B, Streit J, Lademacher C, Joseph-Ridge N.

Arthritis Rheum. 2008 Nov 15;59(11):1540-8. doi: 10.1002/art.24209.

PMID:
18975369
[PubMed - indexed for MEDLINE]
Free Article
17.

Up-titration of allopurinol in patients with gout.

Jennings CG, Mackenzie IS, Flynn R, Ford I, Nuki G, De Caterina R, Riches PL, Ralston SH, Macdonald TM; for the FAST study group.

Semin Arthritis Rheum. 2014 Jan 23. pii: S0049-0172(14)00005-5. doi: 10.1016/j.semarthrit.2014.01.004. [Epub ahead of print]

PMID:
24560169
[PubMed - as supplied by publisher]
18.

Dose adjustment of allopurinol according to creatinine clearance does not provide adequate control of hyperuricemia in patients with gout.

Dalbeth N, Kumar S, Stamp L, Gow P.

J Rheumatol. 2006 Aug;33(8):1646-50.

PMID:
16783857
[PubMed - indexed for MEDLINE]
19.

Clinically insignificant effect of supplemental vitamin C on serum urate in patients with gout: a pilot randomized controlled trial.

Stamp LK, O'Donnell JL, Frampton C, Drake JM, Zhang M, Chapman PT.

Arthritis Rheum. 2013 Jun;65(6):1636-42. doi: 10.1002/art.37925.

PMID:
23681955
[PubMed - indexed for MEDLINE]
Free Article
20.

Plasma oxipurinol concentrations during allopurinol therapy.

Emmerson BT, Gordon RB, Cross M, Thomson DB.

Br J Rheumatol. 1987 Dec;26(6):445-9.

PMID:
3690140
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk